HealthQuest has a team of prominent industry thought leaders to help us evaluate opportunities, source investments and help our portfolio companies connect with their industries.

Bruce Broussard

Bruce Broussard has served as President and CEO of Humana since 2011. Under his leadership, Humana is creating an integrated care delivery model that is expected to drive lower costs, enhanced quality, improved outcomes and a better member experience.

Bruce brings a wide range of executive leadership experience in publicly traded and private organizations within a variety of healthcare sectors, including oncology, pharmaceuticals, assisted living/senior housing, home care, physician practice management, surgical centers, and dental networks.

Prior to joining Humana, Bruce was Chief Executive Officer of McKesson Specialty/US Oncology, Inc.  US Oncology was purchased by McKesson in December 2010.  At US Oncology, Bruce served in a number of senior executive roles, including Chief Financial Officer, President, Chief Executive Officer and Chairman of the Board. Prior to US Oncology, Bruce was CEO of Harbor Dental, following senior executive positions at Regency Health, Sun Healthcare and Continental Medical Systems.

Bruce also plays a leadership role in key business advocacy organizations.  He is a member of the Business Roundtable and a member of the Board of Directors of America’s Health Insurance Plans (AHIP), also serving on AHIP’s Executive Committee.

Bruce holds an MBA from University of Houston and a BBA from Texas A&M Mays Business School.



David King

David P. King is CEO of LabCorp, the world’s leading healthcare diagnostics company. Mr. King began his LabCorp tenure as General Counsel in 2001, and later as EVP and COO of the Company, then becoming CEO in 2007.

Prior to joining the LabCorp, he was a partner with Hogan & Hartson LLP (now Hogan Lovells US LLP) in Baltimore, Maryland from 1992 to 2001. He spent 17 years as a practicing attorney both in private practice and with the US Department of Justice.

Mr. King was appointed to the board of directors of Cardinal Health, Inc. in 2011 and chairs its Human Resources and Compensation Committee. He also sits on the boards of directors of the Seattle Science Foundation, PATH, Inc., and the American Clinical Laboratory Association, and on the board of trustees of Durham Academy. Mr. King has a deep understanding of the clinical laboratory industry, business strategy, sales and marketing and executive management of the Company and its operations.

Mr. King earned a JD degree from the University of Pennsylvania Law School and an AB degree from Princeton University.



Marcus Schabacker, MD, PhD

Since July, 2014 Dr. Schabacker has served as Chief Scientific Officer at Baxter Healthcare Corporation.  In this role, he leads the R&D, Regulatory Affairs, Pharmacovigilance, Medical Affairs and Clinical Development organizations for Medical Products and responsible for driving innovation, enhancing Baxter’s scientific, technical and medical capabilities.

Prior to the CSO appointment, Dr. Schabacker had joined Baxter in March 2011 as the head of R&D for Medical Products.  He lead the integration of multiple R&D teams into one global organization for Medical Products and placed R&D resources closer to our global customer base, including those in fast-growing emerging markets such as China.

Prior to Baxter, Dr. Schabacker held the position of Senior Vice President and Chief Scientific Officer at ConvaTec, Inc.  In his role, Dr. Schabacker had global responsibility for R&D, Regulatory Affairs, Quality Management, Occupational and Environmental Health and Safety, Medical Affairs and Clinical Research. Prior to ConvaTec, Dr. Schabacker was Corporate Vice President, Research and Development at B. Braun Medical.  Under his leadership, more than 10 new medical devices were launched and an innovation management program was implemented.

Prior to B. Braun, Dr. Schabacker also was a consultant with Drägerwerg AG and Senior Medical Officer at Mafikeng General Hospital, in the capital city of Mafikeng, North-West Province, South Africa, where he headed the Anesthesia and Intensive Care Medicine.

Dr. Schabacker has an MD and a Doctorate in anesthesia from Medical University of Lübeck in Germany and certifications in Anesthesiology, Disaster Medicine and Emergency Medicine.



Susan Arnold

Susan Arnold rose through the ranks at Procter & Gamble, ultimately serving as Vice Chairman in 2004, and President of the company in 2007. She had joined Procter & Gamble in 1980 and held several management and marketing positions before becoming the manager of Procter & Gamble's cosmetics business in Canada in 1990. In 1999, she assumed global responsibility for Procter & Gamble's beauty business, thereby becoming the first woman to reach a president-level position in the company. She retired from Procter & Gamble on September 1, 2009.

Ms. Arnold is a member of the board of directors of The Walt Disney Company. She has been a Director of the company since 2007. She has also been a member of the Board of Directors of McDonald's Co. since 2008.

Since 2002, Ms. Arnold has been listed on Fortune Magazine's 50 Most Powerful Women in Business- as #7 in 2008. In 2004 and 2005, she was listed on the Wall Street Journal's 50 Women to Watch. She was listed multiple times on the Forbes list of The World's Most Powerful Women and in 2005 she was #16 on Forbes' The World's 100 Most Powerful Women list. She served for several years on the executive committee of Catalyst, a nonprofit organization working toward the advancement of women in business.

Ms. Arnold graduated from the University of Pennsylvania with a Bachelor of Arts degree, and from the University of Pittsburgh with a Master of Business Administration degree.



William (Bill) Hawkins

portrait-hawkins.png

Bill Hawkins currently serves as President & CEO of Immucor, Inc., a private company, wholly owned by TPG.  Immucor is a market leader in helping secure the world's blood supply through automation. Mr. Hawkins is aSenior Advisor to TPG. Prior to joining Immucor in 2011, Mr. Hawkins served as Chairman and CEO of Medtronic, one of the worlds' largest and most innovative medical technology companies.  

Mr. Hawkins joined Medtronic from Novoste Corp., where he had been President and Chief Executive Officer.  He previously held senior leadership positions at American Home Products, Johnson & Johnson, Guidant Corp., and Eli Lilly & Co.  

Mr. Hawkins is the Chairman of the newly founded Medical Device Innovation Consortium ("MDIC"), and was recently elected as the 2013 President of the American Institute of Medical and Biological Engineering ("AMIBE"). He serves as a Director on the Board of AdvaMedDX, is the Chairman of the Board for KeraNetics and on the Board of Thoratec Corporation, a NYSE-listed medical device company. Mr. Hawkins became a member of the Duke University Board of Trustees in 2011 and serves on the Business and Finance Committee and the Medical Center Academic Affairs Committee. In 2012, he was appointed to the Duke University Health System board and currently serves on the Audit and Compliance Committee.

He has an MBA from University of Virginia's Darden School of Business and a BS in electrical and biomedical engineering from Duke University.


Seth Fischer

Seth_Fischer.jpg

Seth H. Z. Fischer has served as the Chief Executive Officer and director of the Vivus, Inc. since September 3, 2013. Vivus is a biopharmaceutical company committed to the development and commercialization of innovative therapies that focus on advancing treatments for patients with unmet medical needs.  

Prior to Vivus, Mr. Fischer served in positions of increasing responsibility with Johnson & Johnson from 1983 until his retirement in 2012. Mr. Fischer served as Company Group Chairman, Johnson & Johnson, and Worldwide Franchise Chairman, Cardiovascular Devices, from 2008 to 2012, which included responsibility for Cordis and Biosense Webster, and as Company Group Chairman, North America Pharmaceuticals from 2004 to 2007, which included responsibility for Ortho McNeil Pharmaceuticals, Janssen, Scios and McNeil Pediatrics. Mr. Fischer served as President of Ortho-McNeil Pharmaceuticals from 2000 to 2004, with his operating responsibilities encompassing the commercialization of products in multiple therapeutic categories including analgesic, anti-infective, cardiovascular, neurologic, psychiatric and women's health areas.

Mr. Fischer is a member of the board of directors of BioSig Technologies, Inc., Agile Therapeutics, Inc., Marinus Pharmaceuticals, Inc. From April 2013 to September 2013, Mr. Fischer served on the board of Trius Therapeutics, Inc., until it was acquired by Cubist Pharmaceuticals. Mr. Fischer is a graduate of Ohio University and served as a captain in the U.S. Air Force.



William (Bill) Rupp, MD

Dr. William C. Rupp, M.D. serves as Vice President and Chief Executive Officer of Mayo Clinic - Florida at Mayo Clinic Rochester and Mayo Clinic Health Systems. Dr. Rupp served as the President of Luther Hospital (Inc)-Mayo Health System. He led quality projects at Luther Midelfort in Wisconsin, part of the Mayo Health System. He served as President and Chief Executive Officer of Luther/Midelfort Mayo Health System from 1994 to 2001. He served as President of Midelfort Clinic from 1991 to 2001.

Dr. Rupp has extensive experience in quality, change management, safety and team building. Dr. Rupp served as the Chief Executive Officer of Jacksonville Campus of Mayo Clinic (formerly known as Mayo Clinic Rochester) since November 21, 2008. Dr. Rupp served as Chief Executive Officer of Immanuel St. Joseph's Mayo Health System since November 2002. He served as President and Chief Executive Officer of Luther Midelfort - Mayo Health System from 1994 to 2001. He served as President of Midelfort Clinic from 1991 to 2001.

He serves as Internal Trustee of Mayo Clinic Health Systems and has been a Trustee of Mayo Clinic (formerly known as Mayo Clinic Rochester) since 2009. He served as Director of Penobscot Bay Medical Associates. He served as a Director of Cobalt Corporation since 1998 and its Predecessor from 1997 to 1998. He was Practicing Physician in Oncology since 1982. He is a faculty member of the Institute for Health Care Improvement. Dr. Rupp earned an undergraduate degree from Dartmouth University and his Medical degree from the University of Minnesota Medical School in Minneapolis.